Cited by 314

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency

Tang, Binwu, Böttinger, Erwin P., Jakowlew, Sonia B., Bagnall, Kerri M., Mariano, Jennifer, Anver, Miriam R., Letterio, John J., Wakefield, Lalage M.·1998·Nature Medicine

DOI 10.1038/nm0798-802

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nm0798-802

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Genomic sequencing.
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Autocrine growth factors and cancer
Sporn, M. B., & Roberts, A. B. (1985) · Nature · doi:10.1038/313745a0 · Cited by 1,438
Transforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Cytokines in context.
Nathan, C., & Sporn, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.5.981 · Cited by 800
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 746
Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1.
Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., & Schulte-Hermann, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5408 · Cited by 668
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
Fearon, E. R. (1997) · Science · doi:10.1126/science.278.5340.1043 · Cited by 605
Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.
Russell, W. E., Coffey, R. J., Ouellette, A. J., & Moses, H. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5126 · Cited by 425
Tumor suppressor activity of the TGF-β pathway in human cancers
Markowitz, S. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00001-9 · Cited by 416
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15
lavarone, A., & Massagué, J. (1997) · Nature · doi:10.1038/387417a0 · Cited by 377
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.
Flanders, K. C., Thompson, N. L., Cissel, D. S., Van Obberghen-Schilling, E., Baker, C. C., Kass, M. E., Ellingsworth, L. R., Roberts, A. B., & Sporn, M. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.653 · Cited by 370
Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood Pressure: The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study
Cambien, F., Ricard, S., Troesch, A., Mallet, C., Générénaz, L., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.-B., & Poirier, O. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.881 · Cited by 363
Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.
Maroulakou, I. G., Anver, M., Garrett, L., & Green, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11236 · Cited by 363
Self-citation
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., & Jirtle, R. L. (1995) · Nature Genetics · doi:10.1038/ng1295-447 · Cited by 355
Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.
Gorsch, S. M., Memoli, V. A., Stukel, T. A., Gold, L. I., & Arrick, B. A. (1992) · PubMed · Cited by 343
Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
Carr, B. I., Hayashi, I., Branum, E. L., & Moses, H. L. (1986) · PubMed · Cited by 310
High levels of transforming growth factor beta 1 in patients with colorectal cancer: Association with disease progression
Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kiso, S., Imai, Y., Shimomukai, H., Nomura, Y., Matsuda, Y., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566583 · Cited by 284
Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.
Fynan, T., & Reiss, M. (1993) · PubMed · Cited by 236
Pathology of tumors in laboratory animals
Frank, A. L. (1980) · Environmental Research · doi:10.1016/0013-9351(80)90111-5 · Cited by 217
A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women
Langdahl, B. L., Knudsen, J. Y., Jensen, H. K., Gregersen, N., & Eriksen, E. F. (1997) · Bone · doi:10.1016/s8756-3282(96)00363-8 · Cited by 216
Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
Glick, A. B., Kulkarni, A. B., Tennenbaum, T., Hennings, H., Flanders, K. C., O'Reilly, M., Sporn, M. B., Karlsson, S., & Yuspa, S. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6076 · Cited by 207
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.
Naik, P., Karrim, J., & Hanahan, D. (1996) · Genes & Development · doi:10.1101/gad.10.17.2105 · Cited by 202
Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Böttinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. M., & Wakefield, L. M. (1997) · PubMed · Cited by 196
Self-citation
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
Wu, S. P., Theodorescu, D., Kerbel, R. S., Willson, J. K., Mulder, K. M., Humphrey, L. E., & Brattain, M. G. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.1.187 · Cited by 180
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.Preprint
Glick, A. B., Lee, M., Darwiche, N., Kulkarni, A. B., Karlsson, S., & Yuspa, S. H. (1994) · Genes & Development · doi:10.1101/gad.8.20.2429 · Cited by 153
Cyclin-Dependent Kinase Regulation during G1 Phase and Cell Cycle Regulation by TGF-ß
Ravitz, M. J., & Wenner, C. E. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60099-8 · Cited by 145
Sandwich Enzyme-Linked Immunosorbent Assays (Selisas) Quantitate and Distinguish Two Forms of Transforming Growth Factor-Beta (TGF-β1 and TGF-β2) in Complex Biological Fluids
Danielpour, D., Kim, K.-Y., Dart, L. L., Watanabe, S., Roberts, A. B., & Sporn, M. B. (1989) · Growth Factors · doi:10.3109/08977198909069082 · Cited by 124
Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb.
Glick, A. B., Weinberg, W. C., Wu, I. H., Quan, W., & Yuspa, S. H. (1996) · PubMed · Cited by 117
Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern.
Lf, F., Prionas, S. D., Kwan, H. H., Kowalski, J., & ALLISON, A. C. (1996) · PubMed · Cited by 85
The type II transforming growth factor-β receptor as a tumor-suppressor gene
Brattain, M. G., Markowitz, S. D., & Willson, J. K. V. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199601000-00009 · Cited by 63
Altered plasma levels of cytokines in patients with ischemic heart disease
Tashiro, H., Shimokawa, H., Yamamoto, K., Momohara, M., Tada, H., & Takeshita, A. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199703000-00004 · Cited by 57
Specific and sensitive quantitation of transforming growth factor β3 by sandwich enzyme-linked immunosorbent assay
Danielpour, D., & Roberts, A. B. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)00322-n · Cited by 25

TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718

See all 314

Authors: Tang, B., Böttinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., & Wakefield, L. M.
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 1998-07
Volume: 4
Issue: 7
Pages: 802-807
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/nm0798-802
OpenAlex: W2019242560
Cited by: 314
References: 40
FWCI: 7.99
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources